Amphastar Pharmaceuticals(DE:29A)
€25.65-0.35 (-1.35%)
DE:29A
Amphastar Pharmaceuticals Revenue
€25.65
At close:-0.35 (-1.35%)
Amphastar Pharmaceuticals (29A) Revenue
2 Followers
Amphastar Pharmaceuticals Revenue
Amphastar Pharmaceuticals had a revenue of 207.61M in the quarter ending Sep 30, 2026, with 12.89%. This bring the company's revenue in the last twelve months to 745.79M, Increased 2.16%. In the fiscal year ending Dec 31, 2025, Amphastar Pharmaceuticals had annual revenue of 719.89M with -1.65% growth.
- Revenue (ttm)
- 745.79M
- Revenue Growth
- -1.94%
- P/S Ratio
- 1.55
- Revenue/Employee
- EUR 364,315
- Employees
- 1,976
- Market Cap
- EUR 1.12B
Revenue Chart
Amphastar Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 719.89M | -12.08M | -1.65% |
| Dec 31, 2024 | 731.97M | 87.57M | 13.59% |
| Dec 31, 2023 | 644.39M | 145.41M | 29.14% |
| Dec 31, 2022 | 498.99M | 61.22M | 13.98% |
| Dec 31, 2021 | 437.77M | 87.92M | 25.13% |
| Dec 31, 2020 | 349.85M | 27.49M | 8.53% |
| Dec 31, 2019 | 322.36M | 27.69M | 9.40% |
| Dec 31, 2018 | 294.67M | 54.49M | 22.69% |
| Dec 31, 2017 | 240.18M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.